A Study of Pegylated Interferon Alfa-2b as an Adjuvant Treatment in Japanese Patients With Malignant Melanoma (P08556)
by on Tuesday, July 10th, 2012 | No Comments
Condition: Malignant Melanoma
Intervention: Drug: PegIFN alfa-2b
Sponsors: Merck; Merck
Not yet recruiting – verified June 2012
Originally posted here: A Study of Pegylated Interferon Alfa-2b as an Adjuvant Treatment in Japanese Patients With Malignant Melanoma (P08556)